Literature DB >> 15256236

Anaemia prior to operation is related with poorer long-term survival in patients with operable rectal cancer.

H K van Halteren1, S Houterman, C D G W Verheij, V E P P Lemmens, J W W Coebergh.   

Abstract

PURPOSE: Local hypoxia has been linked to a higher risk of metastasis in patients with cancer of the uterine cervix and a haemoglobin concentration of 7.45 mmol/l or less. It is unknown whether the same holds true for rectal cancer. We evaluated the independent impact of pre-operative anaemia on survival in patients with rectal cancer. PATIENTS AND METHODS: A random set of 144 patients diagnosed with Dukes' A, B or C rectal cancer in the period 1995-1999 and registered in the database of the Eindhoven Cancer Registry was included in a survival analysis. Parameters tested were gender, age, pre-operative haemoglobin concentration, tumour stage and therapy. The ones that showed a relation with survival (log-rank test, p<0.1) were entered in a multivariate analysis.
RESULTS: For patients without pre-operative anaemia, the hazard ratio of death was 0.35 (95% confidence interval 0.19-0.65, p=0.001), which indicates a three times higher mortality risk. For patients with a higher tumour stage (Dukes' B vs. Dukes' A or Dukes' C vs. Dukes' B) the hazard ratio of death was 1.52 (95% CI 1.04-2.23, p=0.03). For older patients (64-73 years vs. <64 years or >73 years vs. 64-73 years) the hazard ratio of death was 1.85 (95% CI 1.29-2.63, p=0.001).
CONCLUSION: Long-term survival was significantly affected in rectal cancer patients with pre-operative anaemia. Further study on the relation between anaemia, tumour oxygenation and prognosis is needed, as it may have implications for future therapy.

Entities:  

Mesh:

Year:  2004        PMID: 15256236     DOI: 10.1016/j.ejso.2004.04.014

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  11 in total

1.  Association of preoperative anemia and perioperative allogenic red blood cell transfusion with oncologic outcomes in patients with nonmetastatic colorectal cancer.

Authors:  H Y Kwon; B R Kim; Y W Kim
Journal:  Curr Oncol       Date:  2019-06-01       Impact factor: 3.677

2.  Which comorbid conditions predict complications after surgery for colorectal cancer?

Authors:  Valery E P P Lemmens; Maryska L G Janssen-Heijnen; Saskia Houterman; Kees D G W Verheij; Hendrik Martijn; Lonneke van de Poll-Franse; Jan Willem W Coebergh
Journal:  World J Surg       Date:  2007-01       Impact factor: 3.352

3.  Effect of peri-operative blood transfusions on long-term prognosis of patients with colorectal cancer.

Authors:  Giulia Turri; Corrado Pedrazzani; Giovanni Malerba; Gabriele Gecchele; Cristian Conti; Andrea Ruzzenente; Giuseppe Lippi; Federica Randon; Pierluigi Piccoli; Giorgio Gandini; Domenico Girelli; Alfredo Guglielmi
Journal:  Blood Transfus       Date:  2020-12-22       Impact factor: 3.443

4.  Recombinant human erythropoietin alpha modulates the effects of radiotherapy on colorectal cancer microvessels.

Authors:  W Ceelen; T Boterberg; P Smeets; N Van Damme; P Demetter; O Zwaenepoel; L Cesteleyn; P Houtmeyers; M Peeters; P Pattyn
Journal:  Br J Cancer       Date:  2007-02-13       Impact factor: 7.640

5.  Association between pretreatment haemoglobin levels and morphometric characteristics of the tumour, response to neoadjuvant treatment and long-term outcomes in patients with locally advanced rectal cancers.

Authors:  A A Khan; M Klonizakis; A Shabaan; R Glynne-Jones
Journal:  Colorectal Dis       Date:  2013       Impact factor: 3.788

6.  Preoperative anemia in colorectal cancer: relationships with tumor characteristics, systemic inflammation, and survival.

Authors:  Juha P Väyrynen; Anne Tuomisto; Sara A Väyrynen; Kai Klintrup; Toni Karhu; Jyrki Mäkelä; Karl-Heinz Herzig; Tuomo J Karttunen; Markus J Mäkinen
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

7.  The role of preoperative iron deficiency in colorectal cancer patients: prevalence and treatment.

Authors:  M J Wilson; J W T Dekker; J J Harlaar; J Jeekel; M Schipperus; J J Zwaginga
Journal:  Int J Colorectal Dis       Date:  2017-09-09       Impact factor: 2.571

8.  Predictive Value of FOLFOX-Based Regimen, Long Interval, Hemoglobin Levels and Clinical Negative Nodal Status, and Postchemoradiotherapy CEA Levels for Pathological Complete Response in Patients with Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy.

Authors:  Chun-Ming Huang; Ching-Wen Huang; Cheng-Jen Ma; Yung-Sung Yeh; Wei-Chih Su; Tsung-Kun Chang; Hsiang-Lin Tsai; Suh-Hang Juo; Ming-Yii Huang; Jaw-Yuan Wang
Journal:  J Oncol       Date:  2020-01-28       Impact factor: 4.375

9.  Impact of anaemia at discharge following colorectal cancer surgery.

Authors:  Rebecca C Dru; Nathan J Curtis; Emma L Court; Catherine Spencer; Sara El Falaha; Godwin Dennison; Richard Dalton; Andrew Allison; Jonathan Ockrim; Nader K Francis
Journal:  Int J Colorectal Dis       Date:  2020-06-02       Impact factor: 2.571

10.  Development and Internal Validation of a Nomogram-Based Model to Predict Three-Year and Five-Year Overall Survival in Patients with Stage II/III Colon Cancer.

Authors:  Dan Ren; Wen-Ling Wang; Gang Wang; Wei-Wei Chen; Xiao-Kai Li; Guo-Dong Li; Sai-Xi Bai; Hong-Min Dong; Wang-Hua Chen
Journal:  Cancer Manag Res       Date:  2022-01-14       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.